In a transgenic mouse model of AD, the APP/PS1 mice, the microbiota shows dysbiotic modifications (Traini et al., 2024) and treatments that recover the microbiota functionality shift a high proportion of astrocytes toward a protective phenotype (Lana et al., 2024). Here, PSEN1 is linked to Alzheimer disease.